Oxford University Innovation

Caristo Diagnostics Limited is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of Oxford, the world’s #1 research university, Caristo has developed a portfolio of imaging-based and AI-assisted platforms that can be applied to aid the prediction and diagnosis of heart attack, stroke, and diabetes. Caristo was highlighted by Nature in 2020 as one of the most exciting science-based companies to have emerged from academic labs. To-date Caristo has attracted over £23 million in venture capital investment (nearly US$30 million). Named first of “7 Technologies That Could Change Heart Healthcare Forevermore” by the Robb Report, the CaRi-Heart technology is Caristo’s flagship offering which aids coronary artery disease diagnosis with improved risk prediction. It applies advanced AI algorithms to routine cardiac CT scans to visualize and quantify coronary inflammation, which is the previously invisible root cause of the disease. Each patient’s CaRi-Heart Report includes several clinical results: (1) the patient specific Fat Attenuation Index (FAI), a novel and patented biomarker for the measurement of coronary inflammation, which indicates the patient’s risk in % relative to a matched peer group; (2) CaRi-Heart Risk, which assesses the absolute 8-year risk of a fatal heart attack (based on both coronary inflammation status and standard clinical risks factors); and (3) coronary plaque-specific characterization and quantification. The CaRi-Heart Analysis is supported by the CaRi-Heart software, which is cloud-based and agnostic to the type of scanner generating the routine cardiac CT images. The CaRi-Heart technology is CE Mark certified under the latest EU MDR with UKCA marking being received in September 2022. CaRi-Heart is limited to research use in the U.S. before the FDA grants marketing authorization. Multiple patents underpinning CaRi-Heart technologies have been granted in major jurisdictions around the world. In addition, exceptional validation results showing Cari-Heart’s ability to aid the prediction of heart attacks have been published in leading medical journals including the Lancet, JACC, European Heart Journal, and Cardiovascular Research. CaRi-Heart validation and implementation projects have been supported by multiple UK government grants and awards, including the NHS AI Stage 3 Award for real-world evaluation and implementation of CaRi-Heart care pathway in multiple NHS hospitals. With its deep clinical insights, proven validity and implementation readiness, the CaRi-Heart Analysis Service and the resulting new care pathway can transform cardiac care around the world by aiding in better prediction and prevention of future heart attacks.

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Mach42 is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.

PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.

Arago Biosciences is specialising in label-free single molecule imaging and mass measurement.

Oxford Flow combines the finest minds from academia with global expertise from industry to deliver practical solutions that enable their customers to make their operations quicker and slicker while reducing environmental impact. Oxford Flow is able to save you money without sacrificing performance. Every device is the result of intensive testing and customer feedback. Their solutions aren’t just theoretical - they are proven in the harshest of conditions to work time after time.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to empower patients and clinicians through quantitative assessments of health enabling early detection, diagnosis, and targeted treatment. With a diverse team of physicians, biomedical scientists, engineers, and technologists, Perspectum offers a way to manage complex health problems at scale.

Oxford VR is a spin-out from Oxford University built on the work of Professor Daniel Freeman who has been developing effective VR-based mental health treatments for 15 years. Ground-breaking research, combined with the advent of highly immersive consumer VR, means that they can provide millions of treatments that are: faster and more effective than traditional treatments; significantly lower cost to health providers; loved by users. Their focus is on developing clinically validated, cost-effective, user-centered treatments for clinical conditions with significant impact on patients, the health system, and the wider economy.

Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and ML services Building machine learning models is hard and it can take a lot of trial and error to get them trained, deployed and prove that they are robust. All while providing a strong return on investment. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.

Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and ML services Building machine learning models is hard and it can take a lot of trial and error to get them trained, deployed and prove that they are robust. All while providing a strong return on investment. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.

Oxford Semantic Technologies develop RDFox, the first market-ready high-performance knowledge graph designed from ground up with semantic reasoning in mind. Oxford Semantic Technologies was founded in 2017 as a spin-out of the University of Oxford with a mission to bring cutting-edge research in semantic web technologies to industry. The team started working on RDFox in 2011 at the Computer Science Department of the University of Oxford with the conviction that flexible and high-performance reasoning was a possibility for data extensive applications without jeopardising the correctness of the results. Patented modern computing techniques underpin RDFox’s ability to deliver responses to complex queries on the fly. This has unlocked a new wave of enterprise applications for prestigious partners.

Oxford VR is a spin-out from Oxford University built on the work of Professor Daniel Freeman who has been developing effective VR-based mental health treatments for 15 years. Ground-breaking research, combined with the advent of highly immersive consumer VR, means that they can provide millions of treatments that are: faster and more effective than traditional treatments; significantly lower cost to health providers; loved by users. Their focus is on developing clinically validated, cost-effective, user-centered treatments for clinical conditions with significant impact on patients, the health system, and the wider economy.

Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectual property portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families. Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.

Arago Biosciences is specialising in label-free single molecule imaging and mass measurement.

BibliU provides colleges and universities with digital content management, automation, and analytics platform. BibliU’s solution puts digital textbooks, courseware, and monographs at the fingertips of all students. Working with thousands of publishers and OER providers to deliver millions of digital resources, BibliU combines academic freedom with innovative affordability and automation.

Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases. Peptides offer the potential to make drugs with the specificity and efficacy of large biologic molecules combined with the smaller dose size, simpler routes of delivery and lower cost of manufacturing found with small molecules. They are, therefore, uniquely suited to the treatment of chronic diseases which impact large patient populations. Their technology supports all of the improvements that can be made to peptides which make them better drugs whilst simplifying the discovery process and accelerating drug development

Oxford Flow combines the finest minds from academia with global expertise from industry to deliver practical solutions that enable their customers to make their operations quicker and slicker while reducing environmental impact. Oxford Flow is able to save you money without sacrificing performance. Every device is the result of intensive testing and customer feedback. Their solutions aren’t just theoretical - they are proven in the harshest of conditions to work time after time.

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Oxford Biotrans Ltd is committed to commercialising new enzymatic routes to high value speciality chemicals based on its patented cytochrome P450 enzyme technology. The company is supported by over 15 years of research by Dr Luet Lok Wong from the Department of Chemistry at the University of Oxford. The first products to market will be flavours and fragrances. The technology also has applications in the production of pheromones, pharmaceuticals and other speciality chemicals.

Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and ML services Building machine learning models is hard and it can take a lot of trial and error to get them trained, deployed and prove that they are robust. All while providing a strong return on investment. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.

Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests. The company is a spin-out of the AI research group at Oxford, its automated code-writing capability has far-reaching potential and will eventually transform how software is written. Initially, Diffblue’s technology was deployed to save developers time and ensure robustness in one of software development's most tedious and time-consuming areas: writing unit tests. Diffblue's product stands out from code suggestion tools in that it works completely autonomously, using reinforcement learning to write fully formed tests that are guaranteed to compile, run, and find bugs.

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.

Bodle Technologies is developing SRD®, the world’s first solid-state reflective display technology, based on phase-change materials. Providing vivid colour and video-capability, with zero energy use for static image storage, the technology is ideally suited to address the issues of poor outdoor readability and high power consumption associated with transmissive and emissive displays

Fuel3D is an affordable handheld 3D scanning system that delivers extremely high quality 3D shape and color capture for a range of creative applications. The Fuel3D handheld scanner is a point-and-shoot 3D scanning system that captures extremely high resolution mesh and color information of objects. Fuel3D is the world’s first 3D scanner to combine pre-calibrated stereo cameras with photometric imaging to capture and process files in seconds. But generating high quality 3D images for use in 3D printing or gaming is typically time-consuming and expensive. A handheld 3D scanner today can cost upwards of $15,000, pricing them well above what most independent game developers, designers and artists can afford. Born in Oxford University, Fuel3D is developed by an expert team of hardware and software engineers and scientists. Originally developed for the medical imaging sector, Fuel3D’s technology is being adapted for the broader 3D market, with the goal of bringing the benefits of point-and-shoot 3D imaging to consumers and professionals alike. Originally developed by Professor Ron Daniel, Lecturer in Engineering Science at Oxford University, Fuel3D is today led by Stuart Mead, CEO, a veteran of several successful global technology ventures.

Here at Fungry, they believe Oxford’s best food is found in its independent restaurants. Their fresh and individualistic approach to food means you are given a fantastic plate of grub whatever your mood. They firmly believe in supporting your local - as well as eating quality food. But they also know searching for great local food is time-consuming, and that’s not the point of a takeaway.

Covatic is a Birmingham and Oxford start-up exploring the use of mobile based algorithms to bring smart personalisation to apps. We are a small team of enthusiastic problem solvers, who are always looking for like-minded people to join us and take our products to the next level.

Here at Cycle.land, we are creating a community of bike sharers. We wish to connect people who need a bike with people who have an available bike. Those who share their bikes with others can easily generate a bit of extra money. I trust you know how to spend it wisely :) (coffee and cake anyone?) Not only bikes are an awesome way to get around, there is an added benefit of meeting people who are passionate about cycling, sharing and traveling. You can join Cycle.land wherever you are! I mean it - whether you are in Siberia or Hawaii - Cycle.land is open to you. We will celebrate and get excited about every place. That being said, at the moment all eyes are on Oxford. Here, we wish to create a tight knit community of bike sharers. We are supported by the University of Oxford which is excited about us creating a vibrant social marketplace of students, residents, bike shops, visitors and tourists happily sharing their bikes with one another.

Redacto represents a totally new approach to online language learning. Using authentic recordings of people from different walks of life, as well as news broadcasts and vox pops, Redacto provides English language learners of all levels with intensive and relevant listening practice. Users are supported by hints, score feedback, variable audio speed and Google’s speech to text technology. Students can invite a friend to compete against online. Both users can collaborate in real time as they see each other’s correctly guessed words populate their screens, along with scores and feedback. Learning is consolidated by post listening vocabulary exercises.

Here at Cycle.land, we are creating a community of bike sharers. We wish to connect people who need a bike with people who have an available bike. Those who share their bikes with others can easily generate a bit of extra money. I trust you know how to spend it wisely :) (coffee and cake anyone?) Not only bikes are an awesome way to get around, there is an added benefit of meeting people who are passionate about cycling, sharing and traveling. You can join Cycle.land wherever you are! I mean it - whether you are in Siberia or Hawaii - Cycle.land is open to you. We will celebrate and get excited about every place. That being said, at the moment all eyes are on Oxford. Here, we wish to create a tight knit community of bike sharers. We are supported by the University of Oxford which is excited about us creating a vibrant social marketplace of students, residents, bike shops, visitors and tourists happily sharing their bikes with one another.

Bodle Technologies is developing SRD®, the world’s first solid-state reflective display technology, based on phase-change materials. Providing vivid colour and video-capability, with zero energy use for static image storage, the technology is ideally suited to address the issues of poor outdoor readability and high power consumption associated with transmissive and emissive displays

Xerion Healthcare develop nanoparticles that are used to improve treatment of cancer. The nanoparticles are injected into tumours just prior to standard radiotherapy and act to enhance the effectiveness of the treatment, amplifying the dose of free radicals generated by the X-rays. The nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. Xerion Healthcare are currently developing the treatment for head and neck and pancreatic tumours.

Gyana is a next-gen report and dashboard tool that uses no-code and visual interfaces to give your team the power of top-class data scientists, in just clicks. Data is important, but hard to collect. Insights are important, but hard to come up with. Reports and dashboards are important, but time-consuming and tedious to put together Gyana simplifies the end-to-end data journey, supporting your team each step of the way. Use connectors to automatically bring in the data from all the digital tools you use. Or upload any sort of spreadsheet. Your data will be immediately interpreted and available in Gyana, and it will refresh automatically. COMING SOON: a lot more connectors and collaboration tools are on the way! Use our preset of visualisation and insight models to quickly extract the value from your data. Manipulate the data, play with it, and do all sorts of calculations, in just clicks. No need to know programming languages to get data science-level insights. COMING SOON: Templates and Recipes - pick a use case, and Gyana will tell you what to connect, and automatically create a full report on your case. E.g.: Acquisition Performance Template will ask you to connect a web analytics tool (like Google Analytics), social tools, SEO tools (Google Search Console, Ahref, SEMRush, etc) and more, and then will create a powerful performance review joining all the data from the various sources. Days of work in minutes. Creating a report or a dashboard will take seconds with Gyana. You already created the insights, so you can add them to a customizable report/dashboard in one click. Share the report/dashboard and export them in a pdf. COMING SOON: Report automation - get your report with fresh data straight into your inbox. Also: live public links to dashboards.

Wrapidity is a Web Data Extraction company. Web Data Extraction is the process of turning unstructured (text) and semi-structured (HTML) Web content into structured data (e.g., relational, JSON, RDF) so that it can be queried "like" a database. Most organizations, acquire data from the web by purchasing datasets (CSV or SQL dumps) or by asking an engineer to code a web scraper (e.g., in Python). If you are lucky, your engineers have access to some UI that helps you building the scraper. However, buying datasets is expensive and they become obsolete very quickly, while building (or worse... maintaining) scrapers requires massive engineering time, and engineers are expensive. Wrapidity replaces scraping engineers with an AI, thus making the process of creating and maintaining wrappers automated, scalable and cheap! You only need to give us a small sample of the data you want, our AI will figure out the rest, like: what websites to crawl, how to fill the forms, how the data looks like on the website, and the best way of extracting the entire content, continuously feeding it to the information system of your organisation.

TOTAL MAMA is a new health service concept that helps women before, during, and after pregnancy.

Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.

Oxbotica develops autonomous vehicle software. They provide autonomy software that has low compute power requirements. They use laser vision and radar for localization, redundancy, and cloud management services that enable businesses to help bring autonomy to vehicles.

OXFORD BIO-CHRONOMETRICS was founded in 2014 to develop and deploy technology developed at the Oxford University Innovation center. To date our cyber security software solutions have been realigning the interests of online advertisers, website operators and their consumers. The Company has recently won the NATO 2017 Defense Innovation Challenge for its exceptional technology and has lead the field in industry testing. The Company provides tools to prevent fraud along the entire life cycle of a web interaction, from the view of an ad through the checkout process, 1. Digital Media Solutions are OXFORD BIO-CHRONOMETRICS products that quantify fraud, including its frequency. By identifying non-human (bots) digital advertising fraud - and gathering the data that unambiguously demonstrate it occurred - these tools and services empower advertisers to ensure publisher traffic integrity. And to pay only for traffic that matters. Having established a reliable human baseline, SecureAd Suite of products then applies measurement tools to show whether targets are being hit as intended, both in terms of geographical location and by the websites on which the ads were placed. This generates actionable data that allows advertisers to understand their traffic, to improve their ROI and provide Brand Safety. 2. Cyber Solutions are OXFORD BIO-CHRONOMETRICS’ products that prevent fraud from happening in the first place. These security and accessibility focused tools ensure human-only access, via continuous credential validation methodology that maintain secure sessions. Our entry level product, Secure Form, a passive form of CAPTCHA test is established and gaining traction, with thousands of websites globally using this product to prevent spam and invalid user activity. In addition, we offer SecureLeads, which ensures a human is submitting a Lead or Contact form,and Secure Checkout, which prevents non human generated credit card inputs. Coming soon is our Fake News product!

Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroys cancerous or infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was incorporated in 2007 and is based in Abingdon, United Kingdom.

Oxitec is developing and commercialising an effective and environment-friendly proprietary technology for the control of significant insect pests. Oxitec’s technology has the potential to make a major contribution for both global health and agriculture by combating insects responsible for serious diseases such as dengue fever as well as agricultural damage. The proprietary technology builds on inventions from the University of Oxford and employs genetics and molecular biology to enhance the cost-effectiveness and safety of the existing Sterile Insect Technique (SIT), and to extend SIT to a broader range of insect pests.

OxSyBio's vision is to ultimately produce tissues that can be used by patients in the clinic for precision medicine and organ repair or replacement. At OxSyBio, they are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their technology is based on cutting-edge research conducted by Professor Hagan Bayley’s group in the Chemistry Department at the University of Oxford. A leader in the exploration of chemical and synthetic biology his expertise cover membrane protein structure and function, single molecule chemistry and 3D printing.

Designer Carbon Materials Ltd is developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics. We are producing designer endohedral fullerene molecules with tailored electronic properties. Designer Carbon Materials Ltd is a spin-out company from the University of Oxford. It is based on research led by Dr Kyriakos Porfyrakis and his academic group of 9 researchers. Dr Porfyrakis has been developing methods for the synthesis and chemical functionalization of endohedral fullerenes for over 12 years. Designer Carbon Materials Ltd has licensed the intellectual property portfolio developed by Dr Porfyrakis and his group.

Singular Intelligence offers an AI Platform for brands and retailers that automates and augments commercial decisions at high accuracy, leveraging all market factors. Singular Mission is to build products and solutions that augment human intelligence for smarter decisions with power of Analytics, AI and Big Data.Singular Intelligence is an Oxford University Start up in Analytics and Big Data, Headquartered in UK. We are based out of Oxford University Innovation Limited and Level 39 in Canary Wharf, London.The company’s Innovation focus is on the convergence of consumer, retail, IoT and smart city. SiDAX™ is a big data dynamic insight product and solution leveraging Artificial Intelligence, Visual Analytics and smart data for enabling right time decisions from variety and velocity of data.

Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.

OxCEPT has developed a cross-platform, front-end, mobile application and a back-end server system that provides an extra layer of security for transmitting data. The patents and IP surrounding this proprietary technology allow information to be transmitted securely between any and all devices. Extra Security. Extra Peace Of Mind.

Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.

Oxford MEStar specializing in translational and regenerative medicine. We devote ourselves to a) developing novel technologies; b) offering bioengineering solutions to our clients; and c) technology transfer between the UK and China.

vDabble delivers learning and playtime activities for kids in the ages 3-7 years right to their doors with all supplies.

Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to empower patients and clinicians through quantitative assessments of health enabling early detection, diagnosis, and targeted treatment. With a diverse team of physicians, biomedical scientists, engineers, and technologists, Perspectum offers a way to manage complex health problems at scale.

Starticles is a platform where people can be recognised for the content they create rather than the qualifications they have. Users share their ideas or research, the Starticles community rates this content and users earn recognition through which they can boost their career opportunities.

OxPERT helps micro businesses, particularly tradespeople such as gas engineers and electricians, grow their business and compete with larger competitors through online brand and operations management tools.

OxLegal was created to solve the problems of lawyers, it’s are a software venture which enable firms to leverage on technology in their workflow processes. Lawyers can complete tasks in a fraction of the time, reducing costs and allowing them to focus on higher value strategic work. Reputation is protected through risk mitigation.

edspire is a search engine for online learning resources. It uses sophisticated algorithms to classify MOOCs, videos, OpenCourseWare, tutorials and screencasts. We provide a rich set of tools to enable users to plan their learning journey. There has been a recent massive expansion in educational resources being made available online in a wide variety of formats. This is disrupting the traditional ways in which people are educated both academically and professionally. A major part of this change is the unbundling of the educational experience such that people are using a much greater mixture of providers and methods of learning rather than the single channel of a traditional institution. With so much content, so many platforms and different approaches coming online in a short space of time people need a way to find the appropriate resources for their own situation and learning style – traditional search, such as google is not helpful for this. Our aim is to provide a context for these resources of variegated and unknown quality so that people use the resources that are most helpful in complementing their formal studies or professional development. edspire is incubated by the Isis software incubator, part of Isis Innovation, the technology transfer company of the University of Oxford.

TipTapped is a sports data provider. We analyse social media to find out what people are saying about upcoming sports games. TipTapped aggregate the data to show outcome forecasts for upcoming games, along with the complete prediction histories for each individual.We then share this data with sports fans, sports media and other sports companies.

Oxford Vacmedix was established in 2012 as a spinout from Oxford University. Its aim is to develop therapeutic agents for the treatment of cancer based on the invention of Dr Shisong Jiang - Recombinant Overlapping Peptides (ROP). These agents are an exciting new way to deliver immunotherapy which is now a major focus in the treatment of cancer, making it easier to deliver, more effective and much more economical. Immunotherapy is effective by activating the immune system to attack tumours directly thus reducing the need for invasive treatments such as chemo and radiotherapy.

goKomplain lets you to voice your discontent and allows the public to offer solutions.

SmartEatOut is a group dining solution bringing together people and restaurants. By signing up for free people can join Smart-groups and meet others around the table or simply book a table for a private celebration with their friends.

Oxehealth secures world-first medical device certification for software enabling a digital video camera to remotely detect pulse and breathing rate, with the potential to transform care for elderly and vulnerable people in rooms where staff cannot always be present. Measure pulse rate and breathing rate totally contact free, be alerted to risky activities (for example a dementia patient getting out of bed) and review objective data on activity and vital signs to inform care planning. Oxehealth gives you more time for hands on care. We are the first company in the world to certify software as a medical device which enables a secure optical sensor to measure vital signs from right across a room. Our Digital Care Assistant is paying attention to every room when you can't be there. This Software as a Service solution generates the alerts and reports clinicians, carers and custodians need, seamlessly slotted into their existing workflow. The Digital Care Assistant is helping hundreds of staff in mental health, police, prison care home, acute hospital and home care settings. A spin out from Oxford University's Department of Engineering, Oxehealth’s technology can measure pulse & breathing rate and human activity & behaviour using proprietary algorithms which harness deep learning, computer vision and signal processing techniques. We are growing fast and always on the look out for talented team mates to join us across research, engineering, operations, sales and marketing. Take a look at www.oxehealth.com - we’d love to hear from you.

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Onfido is a provider of automated digital identity verification. The company makes it easy for people to access services by digitally verifying them using its Real Identity Platform.

Building the Workforce of Tomorrow, Today. We help you understand your current workforce and leverage data-driven technology to attract, screen and retain top talent; ensuring that you build diverse and productive teams in the fairest way possible. Everything we do plugs seamlessly into your ATS and CRM, do you don't need to change your processes.

WhatsOnCampus connects students to activities happening on and around their campus.

Award winning digital health platform called "Fuell" with a goal of getting Employees to achieve weekly health goals. Data Collection from wearables Engagement through self service and sponsored challenges Loyalty and Monetisation through tokens Low cost monthly subscription with data driven outcomes for Employers, Brands and Organisations.

Oxford Imaging Detectors develops high performance scientific imaging detectors capable of studying structures and processes at the atomic level.

Esplorio uses social data and our iOS app to create a digital travel journal that you can use to re-live and share your adventures.

Oxford Geo-Social Technologies – OXGEOS™ was founded in March 2012, in Oxford, United Kingdom. OXGEOS has a core team of Oxford Graduates who are motivated by a world of possibilities for geo-social technology.OXGEOS provides world class platforms for social games, social communities and geo-social advertising technologies.

Pilio is a scientifically robust energy-management software. Through the employment of advanced weather analysis algorithms and energy efficiency benchmarking, we can accurately calculate and track your savings. Intuitive, easy-to-access dashboards and reports, designed by building energy experts, are delivered straight to your inbox or via our online platform, empowering you to make lasting financial, energy and carbon savings across your estate.

colwiz (collective wizdom) is a free research management, collaboration and productivity platform for individual researchers, groups, departments and organizations. Utilizing web, desktop (Windows, Mac , Linux) and mobile applications synced in real time, the platform manages the entire research lifecycle from an initial idea, through a complex collaboration, to publication of the results. colwiz The company was founded by leading researchers from the University of Oxford.

IXO Therapeutics Ltd. is a biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.

Kepler Energy was established in 2010 to exploit, with an exclusive licence, an internationally patented 2nd generation tidal turbine developed from 2007 to 2010 by three senior academics at the University of Oxford Department of Engineering Science. Initial work focused upon establishing the performance characteristics of the rotor at 1:20 prototype scale, financed initially by the University, and then, for a second time, with more detailed instrumentation for stress and other measurements, financed by the Technology Strategy Board and by the company's shareholders. Subsequent work has involved developing designs for full scale turbines, combined into tidal fences, undertaken with supply chain partners who are each leaders in the offshore and tidal energy arenas. Kepler has no direct economic competitors in providing access to tidal stream resource where first generation turbines are not economic, and represents the first disruptive technology to positively impact on the economics of power production from this predictable source of sustainable energy. This is because the Kepler turbine is very different to all others on the market - it is larger, scaleable, intrinsically more powerful and patented. It has been optimised to open up new resources in low tidal stream velocity flows (below 2.5 m/s), the most commonly found current strength in coastal waters across the globe. The rotor is deployed in standardised units within a tidal fence arrangement, with the key advantage of generating revenue incrementally during the construction phase, to provide certainty in realising expected equity returns.

Navetas Energy Management Ltd. is an energy management company based in Woodbridge, United Kingdom, established in 2008. It specializes in cloud-based energy monitoring and smart data analytics for connected homes, offering solutions that include the Loop platform for monitoring electricity and gas consumption. The Loop platform provides real-time analytics and automated tariff advice, enabling users to track their energy usage and explore various energy tariffs daily through a secure web interface. Additionally, the company provides the Navetas Zeo Smart Hub, which serves as a communications gateway for various metering services, and the Navetas Zeo Smart Gas Meter that utilizes precision fibre optics for gas meter communication. Navetas markets its services directly to consumers on a subscription basis and through online retailers, aiming to enhance energy measurement, procurement, and conservation across residential and commercial sectors.

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).